Phenobarbital for Acute Alcohol Withdrawal

Completed · Not applicable · Has a placebo group

Conditions studied: Alcohol Withdrawal

In brief

Intravenous phenobarbital in combination with a symptom-guided standardized lorazepam-based alcohol withdrawal protocol will be associated with decreased need for ICU admission, continuous lorazepam infusion and will not be associated with increased adverse events.

Key facts

Study ID

NCT01184417

Run by

Jonathan Rosenson

People needed

102

Starts

2009-01-01

Expected to finish

2010-03-01

Last updated by the study team

2012-03-09

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Need for admission to hospital for acute alcohol withdrawal

You may not qualify if…

• allergy to phenobarbital, lorazepam, age<18 or >65

Where it is running

• Alameda County Medical Center — Oakland, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.